Back to Journals » International Journal of General Medicine » Volume 11

Survey on diabetic patients treated with insulin during the fasting month of Ramadan

Authors Abid M, Hsairi M, Elleuch M, Ben Aissa E

Received 30 December 2016

Accepted for publication 20 April 2017

Published 24 January 2018 Volume 2018:11 Pages 33—40

DOI https://doi.org/10.2147/IJGM.S131308

Checked for plagiarism Yes

Review by Single-blind

Peer reviewers approved by Dr Colin Mak

Peer reviewer comments 2

Editor who approved publication: Dr Scott Fraser


Video abstract presented by Mouna Elleuch.

Views: 219

Mohamed Abid,1 Mohamed Hsairi,2 Mouna Elleuch,1 Emna Ben Aissa3

1Department of Endocrinology, Hedi Chaker Hospital, Sfax, 2Department of Epidemiology, Salah Azaiz Institute, Tunis, 3Medical Department SANOFI, Mégrine, Tunisia

Aim: To estimate the proportion of diabetic patients on insulin, who interrupt fasting during Ramadan, and describe the reported reasons of this interruption.
Design: This is a national observational survey of diabetic patients treated with insulin and fasting during the month of Ramadan 2013, proposed to all endocrinologists willing to participate. Consecutive patients were included until the required sample size, estimated at 498 patients, was obtained. Conducted among patients recruited by endocrinologists during the month following Ramadan 2013.
Results: Five hundred twenty-six (526) patients were included, of which 51 (9.7%) had type 1 diabetes. The mean age was 36.8 ± 11.6 and 58.3 ± 10.0 years for type 1 and type 2 diabetes, respectively. The proportions of male subjects were 62.8% and 57.5% for type 1 and type 2 diabetes, respectively. The mean duration of diabetes was 11.0 ± 8.8 and 14.4 ± 7.9 years for type 1 and type 2 diabetes, respectively. During Ramadan, more than 55% (54.9% and 55.8% for type 1 and type 2 diabetes, respectively) of patients were treated with insulin analog and over a third with mixed insulin. In this study population, 71.5% reported having fasted without interruption during the month of Ramadan. The average number of non-fasted days was 3.0 ± 6.7, mainly due to hypoglycemic episodes.
Conclusion: According to this observational survey conducted in Tunisia, most patients with diabetes treated with insulin (insulin in more than half of the cases) were able to fast without interruption during Ramadan.

Keywords: fasting, Ramadan, insulin, diabetes type 1, diabetes type 2

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]